USO DE ANHIDRASA CARBONICA II PARA LA ELABORACION DE UN MEDICAMENTO

The present invention relates to the field of biomedicine. Specifically, the present invention relates to the use of carbonic anhydrase II for producing a drug for preventing and/or treating damage caused by ischemia, ischemia followed by reperfusion or a toxin, acute failure or rejection of an orga...

Full description

Saved in:
Bibliographic Details
Main Authors VINAS, JOSE LUIS, HOTTER CORRIPIO, GEORGINA, SOLA MARTINEZ, ANNA
Format Patent
LanguageSpanish
Published 18.11.2011
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the field of biomedicine. Specifically, the present invention relates to the use of carbonic anhydrase II for producing a drug for preventing and/or treating damage caused by ischemia, ischemia followed by reperfusion or a toxin, acute failure or rejection of an organ transplant, preferably of a kidney. In a preferred embodiment, the toxin is cisplatin.
Bibliography:Application Number: ES20090030437